Targeted delivery of doxorubicin to the
✍
Lisa H. Treat; Nathan McDannold; Natalia Vykhodtseva; Yongzhi Zhang; Karen Tam;
📂
Article
📅
2007
🏛
John Wiley and Sons
🌐
French
⚖ 416 KB
## Abstract The clinical application of chemotherapy to brain tumors has been severely limited because antitumor agents are typically unable to penetrate an intact blood‐brain barrier (BBB). Although doxorubicin (DOX) has been named as a strong candidate for chemotherapy of the central nervous syst